Insulet Can't Keep Injunction During Trade Secret Appeal
By Elliot Weld · October 23, 2026, 7:51 PM EDT
The Federal Circuit has denied insulin product developer Insulet Corp.'s request to keep an injunction in place against rival EOFlow Co. Ltd. while it appeals an axed $59 million trade secrets...
To view the full article, register now.